References
- National Institute of Healthcare and Excellence. Jaundice in newborn babies under 28 days. NICE; 2010 [updated 2016 Oct].
- Ives NK. Neonatal jaundice. In: Rennie JM, editor. Rennie and Robertson’s textbook of neonatology. 5th ed. Edinburgh: Elsevier. p. 672–690.
- Madan A, Stevenson DK. Neonatal hyperbilirubinemia. In: Taeush HW, Ballard RA, Gleason CA, editors. Avery’s diseases of the newborn. 8th ed. New Delhi: Elsevier Publication; 2005. p. 1226–1256.
- Singh M. Jaundice: Care of the newborn. 7th ed. New Delhi: Sagar Publication; 2010. p. 254–274.
- Brouillard RP. Measurement of red blood cell life-span. JAMA. 1974;230(9):1304–1305.
- Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med. 2001;344(8):581–590.
- Bisceglia M, Indrio F, Riezzo G, et al. The effect of prebiotics in the management of neonatal hyperbilirubinaemia. Acta Paediatr. 2009;98(10):1579–1581.
- Burke BL, Robbins JM, Bird TM, et al. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988–2005. Pediatrics. 2009;123(2):524–532.
- Dollberg S, Atherton HD, Hoath SB. Effect of different phototherapy lights on incubator characteristics and dynamics under three modes of servocontrol. Am J Perinatol. 1995;12(1):55–60.
- Maayan-Metzger A, Yosipovitch G, Hadad E, et al. Transepidermal water loss and skin hydration in preterm infants during phototherapy. Am J Perinatol. 2001;18(7):393–396.
- Martin CR, Cloherty JP. Neonatal hyperbilirubinemia. In: Cloherty JP, editor. Manual of neonatal care. 6th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2008. p. 201.
- Blackburn MG, Orzalesi MM, Pigram P. The combined effect of phototherapy and phenobarbital on serum bilirubin levels of premature infants. Pediatrics. 1972;49(1):110–112.
- Food and Agriculture Organization of the United Nations & World Health Organization. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food London, Ontario, Canada; April 30 and May 1, 2002.
- Yiji CZ, Shi-Xiao W. Characteristics of enterohepatic circulation in neonates and mechanism of using microbiological preparation to treat neonatal jaundice. J Pediatr Pharm. 2003.
- Lefebvre C. Searching for studies. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. New York: Wiley; 2011.
- Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65–W94.
- Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.
- Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
- Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
- Egger M, Davey Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
- Guyatt GH, Oxman AD, Santesso N, et al. GRADE guidelines: 12. Preparing summary of findings tables – binary outcomes. J Clin Epidemiol. 2013;66(2):158–172.
- Schünemann H, Brozek J, Guyatt G, et al. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. GRADE Handbook. 2013. Available from: http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html
- Demirel G, Celik IH, Erdeve O, et al. Impact of probiotics on the course of indirect hyperbilirubinemia and phototherapy duration in very low birth weight infants. J Matern Fetal Neonatal Med. 2013;26(2):215–218.
- Liu W, Liu H, Wang T, et al. Therapeutic effects of probiotics on neonatal jaundice. Pak J Med Sci. 2015;31:5.
- Shadkam M, Jalalizadeh F, Nasiriani K. Effects of probiotic Lactobacillus reuteri (DSM 17938) on the incidence of necrotizing enterocolitis in very low birth weight premature infants. Iran J Neonatal. 2015;6(4):15–20.
- Suganthi V, Das AG. Role of Saccharomyces boulardii in reduction of neonatal hyperbilirubinemia. J Clin Diagn Res: JCDR. 2016;10(11):SC12–SC15.
- Torkaman M, Mottaghizadeh F, Khosravi M, et al. The effect of probiotics on reducing hospitalization duration in infants with hyperbilirubinemia. Iran J Pediatr. 2017;27:e5096.
- Yu M, Chen D, Yin Z. The effect of probiotics on the incidence of neonatal hyperbilirubinemia. Chin J Microecol. 2005. Available from: http://www.en.cnki.com.cn/Article_en/CJFDTOTAL-ZGWS200305016.htm
- Zuo ZHD, Wang Y, Wang C, et al. Probiotics protection against neonatal hyperbilirubinemia. Chin J Med Guide. 2015;11:1143–1145.
- Chandrasekhar J, Gopi A, Raj M, et al. Treatment effect of probiotic Bacillus clausii on neonatal jaundice in late preterm and term newborn babies: an experimental study. Pediatr Ther. 2017;7:3.
- Serce O, Gursoy T, Ovali F, et al. Effects of Saccharomyces boulardii on neonatal hyperbilirubinemia: a randomized controlled trial. Am J Perinatol. 2015;30(2):137–142.
- Serce O, Gursoy T, Karatekin G, et al. Prebiotic and probiotic combination has no effect on indirect hyperbilirubinemia in very low birth weight neonates. J Perinat Med. 2013.
- Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.
- Dani C, Coviello CC, Corsini II, et al. Lactobacillus sepsis and probiotic therapy in newborns: two new cases and literature review. AJP Reports. 2016;6(1):e25–e29.
- Franz CM, Huch M, Abriouel H, et al. Enterococci as probiotics and their implications in food safety. Int J Food Microbiol. 2011;151(2):125–140.
- Zhu K, Holzel CS, Cui Y, et al. Probiotic Bacillus cereus strains, a potential risk for public health in China. Front Microbiol. 2016;7:718.
- Deshpande G, Rao S, Patole S. Probiotics in neonatal intensive care – back to the future. Aust N Z J Obstet Gynaecol. 2015;55(3):210–217.
- Centers for Disease Control and Prevention [Internet]. Fatal gastrointestinal mucormycosis in an infant following use of contaminated ABC dophilus powder from Solgar Inc.; 2014 [cited 2017 Aug 11]. Available from: http://wwwcdcgov/fungal/rhizopus-investigationhtml.
- Mutlu M. Effects of probiotics on neonatal hyperbilirubinemia National Library of Medicine (US). 2016 [cited Jun 2017]. Identifier NCT02807246. Available from: http://clinicaltrials.gov/ct/show/NCT02807246
- Indrio F, Riezzo G, Raimondi F, et al. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr. 2008;152(6):801–806.
- Costalos C, Skouteri V, Gounaris A, et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev. 2003;74(2):89–96.
- Dermyshi E, Wang Y, Yan C, et al. The “golden age” of probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants. Neonatology. 2017;112(1):9–23.
- Harb T, Matsuyama M, David M, et al. Infant Colic—what works: a systematic review of interventions for breast-fed infants. J Pediatr Gastroenterol Nutr. 2016;62(5):668–686.
- Xu M, Wang J, Wang N, et al. The efficacy and safety of the probiotic bacterium Lactobacillus reuteri DSM 17938 for infantile colic: a meta-analysis of randomized controlled trials. PLoS One. 2015;10(10):e0141445.